J. Devulder (London, United Kingdom), K. Raby (London, United Kingdom)
Inflammation and membrane integrity of epithelial cells and macrophages infected by Pseudomonas aeruginosa and Streptococcus pneumoniae
E. Campaña Duel (Sabadell, Spain), L. Morales-Quinteros (Sabadell, Spain), A. Ceccato (Sabadell, Spain), A. Areny-Balagueró (Sabadell, Spain), P. Conde (Barcelona, Spain), L. Blanch (Sabadell, Spain), L. Fernández (Barcelona, Spain), M. Camprubí-Rimblas (Sabadell, Spain), A. Artigas (Sabadell, Spain)
|   |
IL-4 mediated-macrophage reprograming promotes ARDS resolution in the Aging Host
A. Villabona-Rueda (Baltimore, United States), X. Chen (Baltimore, United States), J. Walston (Baltimore, United States), P. Abadir (Baltimore, United States), F. D’Alessio (Baltimore, United States)
| |
IL-33 and IL-4Ra blockade impact distinct and overlapping inflammatory mediators of airway disease
S. Asrat (Tarrytown, United States), G. Scott (Tarrytown, United States), J. Allinne (Tarrytown, United States), W. Lim (Tarrytown, United States), D. Birchard (Tarrytown, United States), L. Ben (Tarrytown, United States), A. Murphy (Tarrytown, United States), M. Sleeman (Tarrytown, United States), J. Orengo (Tarrytown, United States), A. Le Floch (Tarrytown, United States), K. Nagashima (Tarrytown, United States), S. Srivatsan (Tarrytown, United States)
| |
Physiomimetic culture of mesenchymal stromal cells affects macrophage activity in a paracrine manner.
B. Falcones (Lund, Sweden), A. Ibáñez-Fonseca (Lund, Sweden), Z. Söderlund (Lund, Sweden), I. Almendros (Barcelona, Spain), L. Elowsson Rendin (Lund, Sweden), R. Farré (Barcelona, Spain), G. Westergren-Thorsson (Lund, Sweden)
| |
The role of MBD2 regulating M1 macrophage polarization in acute lung injury
W. Sun (Chengdu City, China)
| |
Monocyte Derived Macrophage (MDM) responses to heme stimulation
K. Fytianos (Bern, Switzerland), J. Petracca (Bern, Switzerland), M. Schorer (Bern, Switzerland), F. Kaesermann (Bern, Switzerland)
| |
Late Breaking Abstract - Parenchymal lung abnormalities , clinical severity and outcomes in patients with COVID 19 pneumonia: a prospective longitudinal observational study
A. Prakash (Gurgaon (Haryana), India), B. Datta (Gurgaon (Haryana), India), M. Singh (Gurgaon (Haryana), India), K. Yaddanapudi (tucson,Arizona, United States), K. Ahlawat (Gurgaon (Haryana), India), J. Tripathy (nagpur, India), P. Goyal (Gurgaon (Haryana), India), S. Mittal (Gurgaon (Haryana), India), N. Gupta (Gurgaon (Haryana), India), S. Parvathi (Gurgaon (Haryana), India), A. Jaiswal (Gurgaon (Haryana), India), P. Singh (Gurgaon (Haryana), India), S. Pipavat (seattle,washington, United States), G. Raghu (seattle, washington, United States)
| |
Investigating COVID-19 severity based on serum levels of vascular endothelial growth factor (VEGF)
M. Samareh Fekri (Kerman, Islamic Republic of Iran), E. Barfzade (Kerman, Islamic Republic of Iran), A. Shafahi (Kerman, Islamic Republic of Iran), M. Farokhnia (Kerman, Islamic Republic of Iran), F. Karami Robati (Kerman, Islamic Republic of Iran), S. Movahedinia (Kerman, Islamic Republic of Iran), S. Dabiri (Kerman, Islamic Republic of Iran)
| |
Involvement of the chemerin-ChemR23 system in severe COVID-19 patients
P. Lavis (Brussels, Belgium), S. Morra (Brussels, Belgium), C. Orte Cano (Brussels, Belgium), N. Albayrak (Brussels, Belgium), V. Corbière (Brussels, Belgium), V. Olislagers (Brussels, Belgium), N. Dauby (Brussels, Belgium), V. Del Marmol (Brussels, Belgium), A. Marchant (Brussels, Belgium), C. Decaestecker (Gosselies, Belgium), F. Mascart (Bruxelles, Belgium), P. Van De Borne (Bruxelles, Belgium), I. Salmon (Bruxelles, Belgium), M. Remmelink (Bruxelles, Belgium), M. Parmentier (Bruxelles, Belgium), A. Cardozo (Bruxelles, Belgium), B. Bondue (Bruxelles, Belgium)
| |
Developing advanced cell culture models to study COVID-19-associated pulmonary fibrosis
S. Liu (Leiden, Netherlands), Y. Wang (Leiden, Netherlands), M. Thaler (Leiden, Netherlands), A. Van Schadewijk (Leiden, Netherlands), M. Van Huizen (Leiden, Netherlands), D. Cohen (Leiden, Netherlands), M. Kikkert (Leiden, Netherlands), M. Van Hemert (Leiden, Netherlands), P. Ten Dijke (Leiden, Netherlands), P. Hiemstra (Leiden, Netherlands), A. Van Der Does (Leiden, Netherlands)
| |
Time-dependent molecular motifs of pulmonary fibrogenesis in COVID-19
J. Kamp (Hannover, Germany), L. Neubert (Hannover, Germany), M. Ackermann (Wuppertal, Germany), H. Stark (Hannover, Germany), C. Werlein (Hannover, Germany), J. Fuge (Hannover, Germany), A. Haverich (Hannover, Germany), A. Tzankov (Basel, Switzerland), K. Steinestel (Ulm, Germany), J. Friemann (Lüdenscheid, Germany), P. Boor (Aachen, Germany), K. Junker (Bremen, Germany), M. Hoeper (Hannover, Germany), T. Welte (Hannover, Germany), F. Laenger (Hannover, Germany), M. Kuehnel (Hannover, Germany), D. Jonigk (Hannover, Germany)
| |
Serological markers of tissue remodeling are elevated in patients with COVID-19 who develop interstitial lung disease
H. Breisnes (Herlev, Denmark), P. Juhl (Herlev, Denmark), D. Leeming (Herlev, Denmark), T. Wilkinson (Southampton, United Kingdom), A. Fazleen (Southampton, United Kingdom), J. Sand (Herlev, Denmark)
| |
Balance between a-1Antitrypsin and Human Neutrophil Elastase (a1AT/HNE) in Bronchoalveolar Lavage fluid (BALf) of severe COVID19 patients
V. Vertui (Pavia, Italy), M. D'Amato (Pavia, Italy), S. Viglio (Pavia, Italy), S. Bozzini (Pavia, Italy), M. Morosini (Pavia, Italy), L. Pandolfi (Pavia, Italy), S. Lettieri (Pavia, Italy), M. Della Zoppa (Pavia, Italy), T. Fossali (Milan, Italy), R. Colombo (Milan, Italy), A. Aliberti (Pavia, Italy), P. Iadarola (Pavia, Italy), F. Meloni (Pavia, Italy)
| |
Broncho-alveolar expression of metalloproteinases and tissue growth factors as predictors of clinical severity in Sars-Cov-2 pneumonia
V. Chino (Pavia, Italy), F. Bertuccio (Pavia, Italy), L. Saracino (Pavia, Italy), A. Aliberti (Pavia, Italy), M. Pagani (Pavia, Italy), S. Bozzini (Pavia, Italy), C. Bagnera (Pavia, Italy), S. Lettieri (Pavia, Italy), F. Meloni (Pavia, Italy)
| |
Prolonged stay and endothelial dysfunction in hospitalized patients with covid-19
J. Marquez-Cordero (Mexico City, Mexico), A. Orea-Tejeda (Mexico City, Mexico), D. Gonzalez-Islas (Mexico City, Mexico), L. Cornejo-Cornejo (México City, Mexico), J. Aguilar-Meza (Mexico City, Mexico), A. Rios-Pereda (Mexico City, Mexico), I. Lopez-Vazquez (Mexico City, Mexico), M. Salvatierra-Escobar (Mexico City, Mexico), C. Sanchez-Moreno (Mexico City, Mexico), G. Aztatzi-Aguilar (Mexico City, Mexico), M. Sierra-Vargas (Mexico City, Mexico), Y. Debray-Garcia (Mexico City, Mexico), A. Loaeza-Roman (Mexico City, Mexico), S. Galicia-Amor (Mexico City, Mexico), E. Trejo-Mellado (Mexico City, Mexico)
| |
Correlation between lung inflammatory cells, viral load and cytokines in fatal COVID-19
N. de Souza Xavier Costa (São Paulo, Brazil), J. Erjefält (Lund, Sweden), J. Jönsson (Lund, Sweden), O. Cozzolino (Lund, Sweden), K. Dantas (São Paulo, Brazil), C. Clausson (Lund, Sweden), P. Siddhuraj (Lund, Sweden), C. Lindö (Lund, Sweden), S. Ferreira Spina Lombardi (São Paulo, Brazil), A. Mendroni Júnior (São Paulo, Brazil), L. Antonangelo (São Paulo, Brazil), C. Silvério Faria (São Paulo, Brazil), A. Nunes Duarte Neto (São Paulo, Brazil), R. Almeida Monteiro (São Paulo, Brazil), J. Rebello Pinho (São Paulo, Brazil), M. Soares Gomes-Gouvêa (São Paulo, Brazil), R. Verciano Pereira (São Paulo, Brazil), J. Sirino Monteiro (São Paulo, Brazil), J. Setubal (São Paulo, Brazil), E. Pierre De Oliveira (São Paulo, Brazil), J. Theodoro Filho (São Paulo, Brazil), C. Sanden (Lund, Sweden), J. Orengo (Tarrytown, United States), M. Sleeman (Tarrytown, United States), L. Ferraz Da Silva (São Paulo, Brazil), P. Nascimento Saldiva (São Paulo, Brazil), M. Dolhnikoff (São Paulo, Brazil), T. Mauad (São Paulo, Brazil)
| |
Proteomic profiling of severe lung diffusion impairment in the recovery stage of COVID-19-induced ARDS
M. García-Hidalgo (Lleida, Spain), J. González (Lleida, Spain), I. Benítez (Lleida, Spain), S. Santisteve (Lleida, Spain), F. Rodríguez-Jara (Lleida, Spain), M. Molinero (Lleida, Spain), M. Pérez-Pons (Lleida, Spain), G. Torres (Lleida, Spain), A. Moncusí-Moix (Lleida, Spain), C. Gort-Paniello (Lleida, Spain), P. Carmona (Lleida, Spain), J. Caballero (Lleida, Spain), C. Barberà (Lleida, Spain), A. Tedim (Valladolid, Spain), R. Almansa (Valladolid, Spain), A. Ceccato (Madrid, Spain), L. Fernández-Barat (Barcelona, Spain), R. Ferrer (Barcelona, Spain), D. García-Casulla (Barcelona, Spain), R. Menéndez (Valencia, Spain), A. Motos (Barcelona, Spain), Ó. Peñuelas (Madrid, Spain), J. Riera (Barcelona, Spain), J. Bermejo-Martín (Valladolid, Spain), . Torres (Barcelona, Spain), F. Barbé (Lleida, Spain), D. De Gonzalo-Calvo (Lleida, Spain)
| |
Evaluation of lung inflammation using Exhaled breath condensate in patients with post-COVID syndrome.
A. Portacci (Bari, Italy), P. Pierucci (Bari, Italy), S. Quaranta (Bari, Italy), I. Iorillo (Bari, Italy), C. Locorotondo (Bari, Italy), E. Buonamico (Bari, Italy), F. Diaferia (Bari, Italy), E. Boniello (Bari, Italy), G. Di Gioia (Bari, Italy), M. Grimaldi (Bari, Italy), G. Carpagnano (Bari, Italy)
| |
HLA Class I allele is associated with a lower risk to develop Post-COVID19 interstitial lung manifestations
R. Falfán-Valencia (Ciudad de México (CDMX), Mexico), I. Buendía-Roldán (Ciudad de México (CDMX), Mexico), E. Ambrocio-Ortiz (Ciudad de México (CDMX), Mexico), H. Aguilar-Durán (Ciudad de México (CDMX), Mexico), L. Chávez-Galán (Ciudad de México (CDMX), Mexico), A. Camarena (Ciudad de México (CDMX), Mexico), G. Pérez-Rubio (Ciudad de México (CDMX), Mexico)
| |